Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV

Sep. 27, 2019

Thai vaccine works better in South Africa

Sep. 27, 2019

FDA approves Pifeltro and Delstrigo for virologically suppressed adults with HIV-1 infection

Sep. 23, 2019

Orion Biotechnology obtains Polish clearance to begin phase I study of microbicide gel

Sep. 13, 2019

Gilead discloses new HIV replication inhibitors

Sep. 12, 2019

Parasite protects T cells from HIV

Sep. 10, 2019

Merck & Co. describes HIV integrase inhibitors

Sep. 6, 2019

Dystrophy mutation protects cells from HIV infection

Sep. 6, 2019

HIV rebound shows diverse sources, identical virus

Sep. 3, 2019

New selective and potent class I HDAC inhibitor from Merck activates HIV latency ex vivo

Aug. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...